Get the full picture
Sign in to uncover key details.
ITB Med
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Västra Trädgårdsgatan 15, Stockholm, Sto...Phone Number
(917) 455-4404Website
www.itb-med.comRevenue
<$5 MillionIndustry
About ITB Med
ITB-MED is focused on transforming transplantation by developing a novel therapy that aims to provide immunosuppression freedom for transplant patients. Their innovative approach seeks to improve patient health, enhance quality of life, and reduce healthcare costs associated with lifelong immunosuppression. The company has successfully demonstrated its therapy through real patient stories, such as that of Jennifer Searl, who has lived over 15 years post-kidney transplant without anti-rejection medications. ITB-MED's intended clients are transplant patients looking for improved outcomes and a better quality of life.Explore more
ITB Med Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to ITB Med
Compare insights from companies similar to ITB Med, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ITB Med Tech Stack
A closer look at the technologies used by ITB Med
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ITB Med
Sign Up For FreeTo access detailed company insights
ITB-MED is focused on transforming transplantation by developing a novel therapy that aims to provide immunosuppression freedom for transplant patients. Their innovative approach seeks to improve patient health, enhance quality of life, and reduce healthcare costs associated with lifelong immunosuppression. The company has successfully demonstrated... Read More
